Treatment with 5-Fluorouracil and Celecoxib Displays Synergistic Regression of Ultraviolet Light B-Induced Skin Tumors
- 1 June 2004
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 122 (6) , 1488-1494
- https://doi.org/10.1111/j.0022-202x.2004.22606.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Thymidylate synthase inhibitors as anticancer agents: from bench to bedsideCancer Chemotherapy and Pharmacology, 2003
- Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in miceCarcinogenesis: Integrative Cancer Research, 2003
- Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humansBritish Journal of Dermatology, 2002
- The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2Journal of Biological Chemistry, 2000
- Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesisMolecular Carcinogenesis, 1999
- COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancerCarcinogenesis: Integrative Cancer Research, 1998
- TOPICAL USE OF 5‐FLUOROURACILThe Medical Journal of Australia, 1973
- Selective Cytotoxic Effect of Topical 5-FluorouracilArchives of Dermatology, 1963
- SKIN CHANGES IN PATIENTS TREATED WITH 5-FLUOROURACIL.British Journal of Dermatology, 1962
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957